Evidence map›Paper›PMID 17074812›Full record

ArticleMolecular and cellular biology2007

Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes.

Yong-Tae Ahn, Boli Huang, Lisa McPherson, Carol Clayberger, Alan M Krensky

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. KLF13 cooperates with c-Maf to regulate IL-4 expression in CD4+ T cells.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
  13. Targeting CCL5 in inflammation.Expert opinion on therapeutic targets · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yong-Tae AhnDivision of Immunology and Transplantation Biology, Department of Pediatrics, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5164, USA.
Boli Huang
Lisa McPherson
Carol Clayberger
Alan M Krensky
Stanford University · US

Funding

ANTIGENS IN CTL MEDIATED TRANSPLANT REJECTIONR37DK035008 · NIDDK · STANFORD UNIVERSITY · PI KRENSKY, ALAN MICHAEL · 1997 to 2006
$2.8M
ANTIGENS IN CTL MEDIATED TRANSPLANT REJECTIONR01DK035008 · NIDDK · STANFORD UNIVERSITY · PI KRENSKY, ALAN MICHAEL · 1986 to 1996
–
NIDDK NIH HHS DK 35008NIDDK NIH HHS R37 DK035008
6 · The paper itself

Abstract

The chemokine RANTES (regulated upon activation normal T cell expressed and secreted) is expressed "late" (3 to 5 days) after activation in T lymphocytes. In order to understand the molecular events that accompany changes in gene expression, a detailed analysis of the interplay between transcriptional machinery and chromatin on the RANTES promoter over time was undertaken. Krüppel-like factor 13 (KLF13), a sequence-specific DNA binding transcription factor, orchestrates the induction of RANTES expression in T lymphocytes by ordered recruitment of effector molecules, including Nemo-like kinase, p300/cyclic AMP response element binding protein (CBP), p300/CBP-associated factor, and Brahma-related gene 1, that initiate sequential changes in phosphorylation and acetylation of histones and ATP-dependent chromatin remodeling near the TATA box of the RANTES promoter. These events recruit RNA polymerase II to the RANTES promoter and are responsible for late expression of RANTES in T lymphocytes. Therefore, KLF13 is a key regulator of late RANTES expression in T lymphocytes.

Indexed as

Gene Expression RegulationTranscription, GeneticCell Cycle ProteinsChemokine CCL5ChromatinHumansKineticsKruppel-Like Transcription FactorsLymphocyte ActivationModels, Biologicalp300-CBP Transcription FactorsPromoter Regions, GeneticRepressor ProteinsRNA Polymerase IIRNA, Small InterferingTime FactorsCell Cycle ProteinsChemokine CCL5ChromatinKLF13 protein, humanKruppel-Like Transcription Factorsp300-CBP Transcription FactorsRepressor ProteinsRNA Polymerase IIRNA, Small Interfering

Identifiers

PMID17074812
PMCPMC1800668
OpenAlexW2115677098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.